Derma Sciences, Inc.Princeton, NJ, United States (OTC: DSCI)

Tools:

Buy A ReportBecome A Subscriber

Today's Special Offer

Derma Sciences Financial Statements

Derma Sciences Financial Information

Company Type Public
Headquarters
Fiscal Year-End December
© 2009 Morningstar, Inc. Financial Data provided by Morningstar

Derma Sciences Income Statement

  2008 2007 2006
Revenue ($ mil.) 50.2 34.1 27.9
Gross Profit ($ mil.) 14.9 11.6 9.7
Operating Income ($ mil.) (3.0) (1.6) 1.2
Total Net Income ($ mil.) (4.0) (2.3) 0.7
Diluted EPS (Net Income) (0.10) (0.09) 0.03
More Derma Sciences financial information

Derma Sciences Stock Quote & Chart

11/06/09 14:56:06 EST • NASDAQ OTC BB • 0.60 • Increased by 0.0000 • Increased by 0.0000 %
Quotes delayed 15 minutes for NASDAQ. 20 minutes for NYSE and AMEX. Market Data provided by Interactive Data. Powered and Implemented by Interactive Data Managed Solutions.
Detailed QuoteInteractive Stock Chart

Derma Sciences Financial Ratios

  Company Industry
Median		 Market
Median1
Price/Sales Ratio 0.51 2.38 7.01
Price/Earnings Ratio (9.27) 27.93 25.51
Price/Book Ratio 1.16 2.79 6.74
Price/Cash Flow Ratio 33.78 12.82 43.48
1 Public companies trading on the New York Stock Exchange, the American Stock Exchange, and the NASDAQ National Market.

Detailed Derma Sciences Financial Ratios

Derma Sciences Competitive Intelligence

ConvaTec Covidien Johnson & Johnson
Annual Sales ($ mil.) 0.0 9,910.0 63,747.0
Employees 3,500 41,700 118,700
Market Cap ($ mil.) -- 22,133.0 166,373.7

Competitive Landscape

Copyright © 2009, Hoover's, Inc., All Rights Reserved. Legal Terms | Privacy Policy